KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 137 filers reported holding KRYSTAL BIOTECH INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $114,661,360 | -1.4% | 988,460 | -0.2% | 7.62% | +9.7% |
| Q2 2023 | $116,256,524 | +53.6% | 990,260 | +4.7% | 6.94% | +26.7% |
| Q1 2023 | $75,689,284 | -4.4% | 945,407 | -5.4% | 5.48% | +11.3% |
| Q4 2022 | $79,199,165 | +11.6% | 999,737 | -1.8% | 4.92% | -9.9% |
| Q3 2022 | $70,982,000 | -1.3% | 1,018,388 | -7.0% | 5.47% | -19.5% |
| Q2 2022 | $71,924,000 | +24.8% | 1,095,407 | +26.5% | 6.79% | +38.2% |
| Q1 2022 | $57,640,000 | – | 866,250 | – | 4.91% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 1,913,280 | $153,177,197 | 6.65% |
| Frazier Life Sciences Management, L.P. | 945,407 | $75,689,284 | 5.48% |
| S Squared Technology, LLC | 108,215 | $8,663,693 | 5.14% |
| Nicholas Investment Partners, LP | 374,718 | $29,999,923 | 2.28% |
| Avoro Capital Advisors LLC | 1,750,000 | $140,105,000 | 2.08% |
| Artal Group S.A. | 412,082 | $32,991 | 1.96% |
| First Light Asset Management, LLC | 195,980 | $15,690,159 | 1.41% |
| Integral Health Asset Management, LLC | 85,000 | $6,805,100 | 1.37% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 61,000 | $4,883,660 | 1.36% |
| Hood River Capital Management LLC | 447,393 | $35,818,000 | 1.16% |